GlassScriptPhysician profile
Lauren Chen
NPI 1588240089
$2,444.69
in general payments reported to CMS, 2019-2025
14 companies · $1,117 in 2025
The $1,117 reported for 2025 was more than what 80% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $228 · 2023: $245 · 2024: $854 · 2025: $1,117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,202 · Travel and Lodging: $14.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,202.36 |
| Travel and Lodging | $14.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $792.85 | 2022-2025 | Clareon, Hydrus Microstent, Wavelight Refractive Suite |
| Glaukos Corporation | $344.10 | 2025 | Idosetr, Istent Infinite, Kxl System (Not Refurbished) |
| Bausch & Lomb Americas INC. | $259.38 | 2023-2025 | Xipere, Stellaris, Envista Mx60 Iol |
| Carl Zeiss Meditec USA, INC. | $167.73 | 2024 | Quatera 700, Iolmaster 700 |
| Sun Pharmaceutical Industries INC. | $150.22 | 2024-2025 | |
| Abbvie INC. | $136.52 | 2022-2024 | |
| Genentech USA, INC. | $134.09 | 2024 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $120.79 | 2024 | Syfovre |
| Regeneron Healthcare Solutions, INC. | $107.79 | 2024 | Eylea Hd |
| Dompe US, INC. | $105.31 | 2025 | Oxervate |
| New World Medical,INC. | $50.01 | 2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Sight Sciences, INC. | $29.01 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Ani Pharmaceuticals, INC. | $25.46 | 2025 | Yutiq |
| Genentech, INC. | $21.43 | 2024 | Vabysmo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.